Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Cardiotoxicity 6Lymphoma 3Heart Failure 3Hematologic Neoplasms 2Glioblastoma 2Carcinoma, Hepatocellular 2Ventricular Dysfunction 1Sarcoma 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Multiple Myeloma 1Motor Activity 1Leukemia, Myeloid, Acute 1Leukemia 1Hypertension, Portal 1Hepatocellular Carcinoma With Portal Vein Thrombosis 1Esophageal and Gastric Varices 1Cardiovascular Abnormalities 1Cardiomyopathies 1Breast Neoplasms, Male 1Brain Neoplasms 1

Interventions

epicatechin gallate 1Valsartan 1Therapeutics 1Standard of Care 1Restraint, Physical 1Practice Guidelines as Topic 1Mesenchymal Stem Cell Transplantation 1Exercise 1Carvedilol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cardiomyopathies × Carvedilol × Clear all
NCT04023110 2025-10-09

CCTGuide Pilot

Abramson Cancer Center at Penn Medicine

Phase 1 Completed
68 enrolled 20 charts
Breast

Breast Neoplasms, Heart Failure, Cardiomyopathies, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡